New gout pill tested against standard treatment in major trial
NCT ID NCT06139393
Summary
This study tested whether a new medication called HR091506 works as well as an existing drug (febuxostat) to lower uric acid and control gout in adults. It involved 765 people with gout and high uric acid levels over 28 weeks. The main goal was to see if the new pill could safely get more people's uric acid down to a healthy target level.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT WITH HYPERURICEMIA IN ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.